Clinical trial · Interventional
A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions
Development and Validation of a Predictive Model for Early Gastric Cancerous Lesions Under Endoscopic Observation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Without high diagnostic efficacy of endoscopic forceps biopsy (EFB) and with low diagnostic efficacy of narrow band imaging (NBI) in novice endoscopists and endoscopists of community hospitals in China, it is urgent to improve diagnostic efficacy for gastric cancerous lesions.The investigators will conduct a study to develop and validate a diagnostic model based on NBI for early gastric cancerous lesions under endoscopic observation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Early Gastric Cancer | Early Gastric Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| NBI | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Suspected gastric cancerous lesions
- description
- Magnifying endoscopy with NBI would be conducted for every patient included in our study
- interventionNames
- Device: NBI
Primary outcomes (1)
- measure
- Accuracy of the diagnostic model in histological prediction of gastric cancerous lesions
- timeFrame
- 36 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Suspected of having a cancerous lesions * The age of patients is from 40-80 years * Patients must undergo esophagogastroduodenoscopy Exclusion Criteria: * Clinical diagnosis of advanced gastric cancer * Acute upper gastrointestinal bleeding * Severe systemic diseases * Refuse to attend the study
References
Publications (0)
Data not yet available